The state of point-of-care testing: A european perspective

Upsala Journal of Medical Sciences

Volumn 120, Issue 1, 2015, Pages 1-10

  Larsson, Anders ^a   Greig Pylypczuk, Roman ^b   Huisman, Albert ^c  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Laboratory analyses; Near patient testing; Outcome measurements; Point of care

Indexed keywords

DECISION MAKING; EUROPE; HEALTH CARE QUALITY; HUMAN; NONBIOLOGICAL MODEL; POINT OF CARE TESTING; QUALITY CONTROL; REPRODUCIBILITY; RISK; STANDARDS;

DECISION MAKING; EUROPE; HUMANS; MODELS, ORGANIZATIONAL; POINT-OF-CARE TESTING; QUALITY ASSURANCE, HEALTH CARE; QUALITY CONTROL; QUALITY OF HEALTH CARE; REPRODUCIBILITY OF RESULTS; RISK;

EID: 84930941489     PISSN: 03009734     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009734.2015.1006347     Document Type: Review

References (59)

1. European Commission. Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices. Brussels, Belgium: European Commission 1998. Available from http://ec.europa.eu/enterprise/policies/european-standards/harmonised-standards/ivdiagnostic-medical-devices/. Last accessed 7 December 1998.
2. International Organization for Standardization. Point of care (POC): Requirements for quality and competence (ISO 22870:2006). Geneva, Switzerland: International Organization for Standardization 2006. Available from http://www.iso.org/iso/catalogue-detail.htm?csnumber=35173. Last accessed 01 February 2006.
3. International Organization for Standardization. Medical laboratories: Particular requirements for quality and competence (ISO 15189:2012). Geneva, Switzerland: International Organization for Standardization 2012. Available from http://www.iso.org/iso/home/store/catalogue-ics/catalogue-detail-ics.htm?csnumber=56115. Last accessed 01 November 2012.
4. Scalise D. Poised for growth. point-of-care testing. Hosp Health Netw. 2006;80:77-83.
5. Kendall J, Reeves B, Clancy M. Point of care testing: randomised controlled trial of clinical outcome. BMJ. 1998;316:1052-7.
6. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med. 2009;361:858-67.
7. Luepker RV, Raczynski JM, Osganian S, Goldberg RJ, Finnegan JR Jr, Hedges JR, et al. Effect of a community intervention on patient delay and emergency medical service use in acute coronary heart disease: The Rapid Early Action for Coronary Treatment (REACT) Trial. JAMA. 2000;284:60-7.
8. Neumann FJ, Kastrati A, Pogatsa-Murray G, Mehilli J, Bollwein H, Bestehorn HP, et al. Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial. JAMA. 2003;290:1593-9.
9. Tricoci P. Time to coronary angiography in patients with non-ST-segment elevation acute coronary syndrome: how fast should patients go to the catheterization laboratory? Curr Opin Cardiol. 2008;23:585-90.
10. Tricoci P, Lokhnygina Y, Berdan LG, Steinhubl SR, Gulba DC, White HD, et al. Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYN-ERGY trial. Circulation. 2007;116:2669-77.
11. Goodacre S, Bradburn M, Fitzgerald P, Cross E, Collinson P, Gray A, et al. The RATPAC (Randomised Assessment of Treatment using Panel Assay of Cardiac markers) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department. Health Technol Assess. 2011;15:1-102.
12. Rust G, Gailor M, Daniels E, McMillan-Persaud B, Strothers H, Mayberry R. Point of care testing to improve glycemic control. Int J Health Care Qual Assur. 2008;21:325-35.
13. Renaud B, Maison P, Ngako A, Cunin P, Santin A, Hervé J, et al. Impact of point-of-care testing in the emergency department evaluation and treatment of patients with suspected acute coronary syndromes. Acad Emerg Med. 2008;15:216-24.
14. Storrow AB, Zhou C, Gaddis G, Han JH, Miller K, Klubert D, et al. Decreasing lab turnaround time improves emergency department throughput and decreases emergency medical services diversion: a simulation model. Acad Emerg Med. 2008;15:1130-5.
15. Laurence CO, Gialamas A, Bubner T, Yelland L, Willson K, Ryan P, et al. Patient satisfaction with point-of-care testing in general practice. Br J Gen Pract. 2010;60:e98-104.
16. Gialamas A, Yelland LN, Ryan P, Willson K, Laurence CO, Bubner TK, et al. Does point-of-care testing lead to the same or better adherence to medication? A randomised controlled trial: the PoCT in General Practice Trial. Med J Aust. 2009;191:487-91.
17. Bubner TK, Laurence CO, Gialamas A, Yelland LN, Ryan P, Willson KJ, et al. Effectiveness of point-of-care testing for therapeutic control of chronic conditions: results from the PoCT in General Practice Trial. Med J Aust. 2009;190:624-6.
18. Hinds LE, Brown CL, Clark SJ. Point of care estimation of haemoglobin in neonates. Arch Dis Child Fetal Neonatal Ed. 2007;92:F378-80.
19. Huisman A, Van Solinge WW. Point-of-care testing in hematology. In Price C, St John A, Hicks JM, editors. Point-of-care testing. 2nd ed Washington DC: AACC Press; 2004.
20. Madan A, Kumar R, Adams MM, Benitz WE, Geaghan SM, Widness JA. Reduction in red blood cell transfusions using a bedside analyzer in extremely low birth weight infants. J Perinatol. 2005;25:21-5.
21. Mahieu L, Marien A, De Dooy J, Mahieu M, Mahieu H, Van Hoof V. Implementation of a multi-parameter Point-of-Care-blood test analyzer reduces central laboratory testing and need for blood transfusions in very low birth weight infants. Clin Chim Acta. 2012;413:325-30.
22. Widness JA, Madan A, Grindeanu LA, Zimmerman MB, Wong DK, Stevenson DK. Reduction in red blood cell transfusions among preterm infants: results of a randomized trial with an in-line blood gas and chemistry monitor. Pediatrics. 2005;115:1299-306.
23. Asha SE, Chan AC, Walter E, Kelly PJ, Morton RL, Ajami A, et al. Impactfrompoint-of-caredevicesonemergencydepartment patient processing times compared with central laboratory testing of blood samples: a randomised controlled trial and cost-effectiveness analysis. Emerg Med J. 2014;31:714-19.
24. Chin CD, Cheung YK, Laksanasopin T, Modena MM, Chin SY, Sridhara AA, et al. Mobile device for disease diagnosis and data tracking in resource-limited settings. Clin Chem. 2013;59:629-40.
25. Weber CF, Zacharowski K. Perioperative point of care coagulation testing. Dtsch Arztebl Int. 2012;109:369-75.
26. Plebani M. Appropriateness in programs for continuous quality improvement in clinical laboratories. Clin Chim Acta. 2003;333:131-9.
27. Mindemark M, Larsson A. Longitudinal trends in laboratory test utilization at a large tertiary care university hospital in Sweden. Ups J Med Sci. 2011;166:34-8.
28. Lee-Lewandrowski E, Lewandrowski K. Implementing point-of-care testing to improve outcomes. J Hosp Admin. 2013;2:125-32.
29. Boyle A, Beniuk K, Higginson I, Atkinson P. Emergency department crowding: time for interventions and policy evaluations. Emerg Med Int. 2012;2012:838610.
30. Coughlan M, Corry M. The experiences of patients and relatives/significant others of overcrowding in accident and emergency in Ireland: a qualitative descriptive study. Accid Emerg Nurs. 2007;15:201-9.
31. Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med. 2004;350:647-54.
32. Bradburn M, Goodacre SW, Fitzgerald P, Coats T, Gray A, Hassan T, et al. RATPAC Research Team. Interhospital variation in the RATPAC trial (Randomised Assessment of Treatment using Panel Assay of Cardiac markers). Emerg Med J. 2012;29:233-8.
33. Cole LA. Human chorionic gonadotropin tests. Expert Rev Mol Diagn. 2009;9:721-47.
34. Fromm C, Likourezos A, Haines L, Khan AN, Williams J, Berezow J. Substituting whole blood for urine in a bedside pregnancy test. J Emerg Med. 2012;43:478-82.
35. Galloway MJ, Woods RS, Nicholson SL, Foggin JJ, Elliott L. An audit of waiting times in a haematology clinic before and after the introduction of point-of-care testing. Clin Lab Haematol. 1999;21:201-5.
36. Geersing GJ, Janssen KJ, Oudega R, Bax L, Hoes AW, Reitsma JB, et al. Excluding venous thromboembolism using point of care D-dimer tests in outpatients: a diagnostic metaanalysis. BMJ. 2009;339:b2990.
37. Lee-Lewandrowski E, Nichols J, Van Cott E, Grisson R, Louissaint A, Benzer T, et al. Implementation of a rapid whole blood D-dimer test in the emergency department of an urban academic medical center: impact on ED length of stay and ancillary test utilization. Am J Clin Pathol. 2009;132:326-31.
38. Keeling D, Baglin T, Tait C, Watson H, Perry D, Baglin C, et al. British Committee for Standards in Haematology. Guidelines on oral anticoagulation with warfarin - fourth edition. Br J Haematol. 2011;154:311-24.
39. Giles MT, Parker V, Bevan H, Wright IM. Comparing Point of Care International Normalised Ratio testing with laboratory testing methods in a cardiac inpatient population. J Clin Nurs. 2010;19:3085-91.
40. Lawrie AS, Hills J, Longair I, Green L, Gardiner C, Machin SJ, et al. The clinical significance of differences between point-of-care and laboratory INR methods in overanticoagulated patients. Thromb Res. 2012;130:110-14.
41. Taborski U, Wittstamm FJ, Bernardo A. Cost-effectiveness of self-managed anticoagulant therapy in Germany. Semin Thromb Hemost. 1999;25:103-7.
42. Forde D, O'Connor MB, Gilligan O. Potentially avoidable inpatient nights among warfarin receiving patients;anauditofasingle university teaching hospital. BMC Res Notes. 2009;2:41.
43. Miele V, Andreoli C, Grassi R. The management of emergency radiology: key facts. Eur J Radiol. 2006;59:311-14.
44. Huisman A. Needs analysis and selection of point-of-care testing analyzers. In Kottke-Marchant K, Davis BH, editors. Laboratory hematology practice. Oxford, UK: Wiley-Blackwell; 2012:668-72.
45. Pecoraro V, Germagnoli L, Banfi G. Point-of-care testing: where is the evidence? A systematic survey. Clin Chem Lab Med. 2014;52:313-24.
46. Kitchen DP, Kitchen S, Jennings I, Woods TA, Walker ID, Preston FE. Point of care testing by health care professionals: current practice amongst the UK National External Quality Assessment Scheme Participants. Br J Heamatol. 2005;130:320-1.
47. Briggs C, Carter J, Lee SH, Sandhaus L, Simon-Lopez R, Vives Corrons JL. ICSH Guideline for worldwide point-ofcare testing in haematology with special reference to the complete blood count. Int J Lab Hematol. 2008;30:105-16.
48. Briggs C, Guthrie D, Hyde K, Mackie I, Parker N, Popek M, et al. British Committee for Standards in Haematology General Haematology Task Force. Guidelines for point-of-care testing: haematology. Br J Heamatol. 2008;142:904-15.
49. Pernet P, Goudable J, Annaix V, Vaubourdolle M, Szymanowicz A. [Guidelines for the formation of a multidisciplinary group for point-of-care testing supervision according to EN ISO 22870]. Ann Biol Clin (Paris). 2012;70:161-6.
50. Clinical governance in the new NHS (Health Service Circular: (99) 065). London, United Kingdom: Department of Health, Government of the United Kingdom 1999. Available from http://webarchive.nationalarchives.gov. uk/+/www.dh.gov. uk/en/Publicationsandstatistics/Lettersandcirculars/Healthservicecirculars/DH-4004883. Last accessed 16 March 1999.
51. Scally G, Donaldson LJ. The NHS's 50 anniversary. Clinical governance and the drive for quality improvement in the new NHS in England. BMJ. 1998;317:61-5.
52. Pearson J. Point-of-care-testing and clinical governance. Clin Chem Lab Med. 2006;44:765-7.
53. Lewandrowski K, Gregory K, Macmillan D. Assuring quality in point-of-care testing: evolution of technologies, informatics, and program management. Arch Pathol Lab Med. 2011;135:1405-14.
54. Briggs C, Kimber S, Green L. Where are we at with point-ofcare testing in haematology? Br J Heamatol. 2012;158:679-90.
55. Briggs C, Longair I, Kumar P, Singh D, Machin SJ. Performance evaluation of the Sysmex haematology XN modular system. J Clin Pathol. 2012;65:1024-30.
56. Hollis VS, Holloway JA, Harris S, Spencer D, Van Berkel C, Morgan H. Comparison of venous and capillary differential leukocyte counts using a standard hematology analyzer and a novel microfluidic impedance cytometer. PLoS ONE. 2012;7:e43702.
57. Papadea C, Foster J, Grant S, Ballard SA, Cate JC, Southgate WM, et al. Evaluation of the i-STAT Portable Clinical Analyzer for point-of-care blood testing in the intensive care units of a university children's hospital. Ann Clin Lab Sci. 2002;32:231-43.
58. Rao LV, Ekberg BA, Connor D, Jakubiak F, Vallaro GM, Snyder M. Evaluation of a new point of care automated complete blood count (CBC) analyzer in various clinical settings. Clin Chim Acta. 2008;389:120-5.
59. Wallvik J, Sjalander A, Johansson L, Bjuhr O, Jansson JH. Bleeding complications during warfarin treatment in primary healthcare centres compared with anticoagulation clinics. Scand J Prim Health Care. 2007;25:123-8.